Skip to main content

Future of Global Nuclear Cardiology Market: 2015 - 2021

Press Release   •   Feb 03, 2017 01:22 EST

Nuclear imaging in cardiac disorders aids in accurate diagnosis of cardiovascular diseases and blockages in blood flow. Nuclear imaging is a technique for producing images of various body parts utilizing radioactive materials. This technique has applications in diagnosis of various cardiovascular diseases such as angina, aneurysm, atherosclerosis, stroke, coronary artery disease and congestive heart failure. Accurate diagnosis of such chronic diseases is essential to plan precise and cost-effective therapeutic module.

The nuclear cardiology market is focused mainly on three major segments namely, radiology devices, picture archiving and communications systems (PACS) and radiology information systems (RIS) and radiopharmaceuticals. Gamma cameras and positron emission tomography scanners are major imaging devices used in cardiac procedures. SPECT imaging has been the mainstream modality for nuclear cardiology procedures performed worldwide. Radiopharmaceuticals such as nitrogen-13, rubidium-82, fluorine-18, oxygen-15 and other radioisotopes are used in the nuclear imaging process. PACS is an emerging and promising technology in nuclear imaging sector with its potential benefits over other imaging technologies.

A Sample of this Report is Available Upon Request @

Geographically, this market is categorized into North America, Europe, Asia-Pacific and Rest of the World. Better capacities to handle new and highly advanced technologies have kept North America ahead of the other regions in terms of the nuclear cardiology market. However, catering to the untapped opportunities in the Asia-Pacific and Latin American regions will drive these regions at a faster growth rate.

Aging population and rising cardiovascular incidences are the major driving factors for the nuclear cardiology market. Besides, the demand for graying equipment in the established diagnostic facilities will provide with demand for new equipment with improve patient outcomes and reduced radiation exposure. In addition, new cost effective technologies such as PET and PACS imaging equipment will lead to growth in the demand for nuclear cardiology devices.

To View TOC of this Report is Available Upon Request @

Some of the major players in this market include 3mensio Medical Imaging BV, Bracco Diagnostics, Inc., GE Healthcare, Shimadzu Corporation, Siemens Healthcare, Astellas Pharma US, Inc., Philips Healthcare, Covidien plc, Positron Corporation, Fujifilm Medical Systems USA, Inc. and UltraSPECT, Ltd.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City, 

NY 10007, United States,

USA - Canada Toll Free: 800-961-0353



Comments (0)

Add comment